Our recent paper in Advanced Biosystems titled “Droplet‐Microarray: Miniaturized Platform for High‐Throughput Screening of Antimicrobial” is online now. Congratulations to Wenxi and the co-authors! Great collaboration with Thomas Schwartz´s group at KIT.
The authors demonstrated the droplet‐microarray (DMA) platform can be used for screening the efficiency of clinically used antibiotics against bacterial pathogens. This platform offers the ability to investigate drug‐resistance of bacteria isolated from patients and the environment with minimal cost and effort.
ABOUT THE GROUP
Our research group is located at the Karlsruhe Institute of Technology and affiliated with the University of Heidelberg. Our research is focused on the synthesis and application of biofunctional materials, surfaces and nanoparticles.
Wenxi’s paper in Adv. Biosyst. is online
- Details